Smoking affects the phenotype of Alzheimer disease

Because epidemiologic and in vitro evidence conflict, the authors studied the association between smoking and Alzheimer disease (AD) in 46 never, 47 former, and 15 active smokers with AD followed to autopsy. Disease parameters were examined by smoking status and amount smoked in bivariate tests and in multivariate models controlling for age, sex, education, and APOE status. Smoking status was not associated with cognitive or neuropathologic measures. However, active smokers were significantly younger at death and higher levels of smoking were associated with shorter disease duration.

[1]  D. Foley,et al.  Mid-life smoking and late-life dementia: the Honolulu-Asia Aging Study , 2003, Neurobiology of Aging.

[2]  Kenjiro Ono,et al.  Nicotine breaks down preformed Alzheimer’s β-amyloid fibrils in vitro , 2002, Biological Psychiatry.

[3]  J. Buxbaum,et al.  Nicotinic receptor subtypes in human brain ageing, Alzheimer and Lewy body diseases. , 2000, European journal of pharmacology.

[4]  A. Hofman,et al.  Smoking and risk of dementia and Alzheimer's disease in a population-based cohort study: the Rotterdam Study , 1998, The Lancet.

[5]  H. Stähelin,et al.  Does smoking protect from Alzheimer’s disease? Alzheimer-type changes in 301 unselected brains from patients with known smoking history , 1997, Acta Neuropathologica.

[6]  S. Shimohama,et al.  Nicotine‐induced Protection Against Glutamate Cytotoxicity , 1996 .

[7]  S. Shimohama,et al.  Nicotine-induced protection of cultured cortical neurons againstN-methyl-D-aspartate receptor-mediated glutamate cytotoxicity , 1994, Brain Research.

[8]  S. Lin-Chao,et al.  Reduced Inhibition of DNA Synthesis and G(2) Arrest during the Cell Cycle of Resistant HeLa Cells in Response to cis-Diamminedichloroplatinum. , 1994, Journal of biomedical science.

[9]  D. Salmon,et al.  Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment , 1991, Annals of neurology.

[10]  N. Greig,et al.  Nicotine lowers the secretion of the Alzheimer's amyloid beta-protein precursor that contains amyloid beta-peptide in rat. , 2002, Journal of Alzheimer's disease : JAD.

[11]  Kenjiro Ono,et al.  Nicotine breaks down preformed Alzheimer's beta-amyloid fibrils in vitro. , 2002, Biological psychiatry.

[12]  N. Greig,et al.  Nicotine lowers the secretion of the Alzheimer's amyloid β-protein precursor that contains amyloid β-peptide in rat , 2002 .

[13]  S. Shimohama,et al.  Nicotine-induced protection against glutamate cytotoxicity. Nicotinic cholinergic receptor-mediated inhibition of nitric oxide formation. , 1996, Annals of the New York Academy of Sciences.

[14]  P. Lee,et al.  Smoking and Alzheimer's disease: a review of the epidemiological evidence. , 1994, Neuroepidemiology.